Clinical trials: Diarrhea Bloody, open to volunteers
Multiple Myeloma, Plasma Cell Leukemia
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant
A randomized placebo controlled, phase 2 study of budesonide in subjects with multiple myeloma undergoing autologous stem cell transplant (ACST). The study includes a run-in period with 20 patients.
- Trial name
- IMPACT (NCT05405387)
- Testing
- Budesonide EC
- Where
- United States
- Volunteers
- 120 people
- Sponsor
- University of Utah